2013's Information

2013/03/04

5th China & 3rd Asia Clinical Trials Outsourcing Congress

2013/02/28

Patent established additional usage in Japan of F647 and F351 to cover application for Preventing Radiation-Caused Lung Injury in Japan, also in the U.S. obtained patent for pharmaceutical composition of F200

2013/02/14

Announcement of the 12th Annual General Shareholder Meeting

2013/02/04

Submission of Manufacturing and Distribution Permission Application regarding IPF treatment drug, F647

2013/01/23

GNI Seeks New Indication for F647 (Pirfenidone)

2013/01/16

Notice of Increasing the Capital of Shanghai Genomics